|
| Exchange Disseminated Time 30/05/2016 22:03:30 | Sun Pharmaceutical Industries Ltd has announced the following results for the quarter & year ended March 31, 2016
The Audited Standalone results for the Quarter ended March 31, 2016
The Company has posted a net profit of Rs. 617.10 million for the quarter ended March 31, 2016 where as the same was at net loss of Rs. (793.40) million for the quarter ended March 31, 2015. Total Income is Rs. 22474.70 million for the quarter ended March 31, 2016 where as the same was at Rs. 19612.80 million for the quarter ended March 31, 2015.
The Audited Standalone results for the Year ended March 31, 2016
The Company has posted a net loss of Rs. (10733.60) million for the year ended March 31, 2016 where as the same was at net loss of Rs. (14741.30) million for the year ended March 31, 2015. Total Income is Rs. 78317.00 million for the year ended March 31, 2016 where as the same was at Rs. 81334.20 million for the year ended March 31, 2015.
The Consolidated Results are as follows:
The Audited Consolidated results for the Quarter ended March 31, 2016
The Group has posted a net profit of Rs. 17136.90 million for the quarter ended March 31, 2016 where as the same was at Rs. 8892.40 million for the quarter ended March 31, 2015. Total Income is Rs. 75992.10 million for the quarter ended March 31, 2016 where as the same was at Rs. 65050.40 million for the quarter ended March 31, 2015.
The Audited Consolidated results for the Year ended March 31, 2016
The Group has posted a net profit of Rs. 47159.10 million for the year ended March 31, 2016 where as the same was at Rs. 45393.80 million for the year ended March 31, 2015. Total Income is Rs. 287289.50 million for the year ended March 31, 2016 where as the same was at Rs. 278428.40 million for the year ended March 31, 2015. |
|
|